Annovis Bio Inc (ANVS)

[McMagyar]

so when news comes out for the 68 Clinical Pariticpants..this is the data we are looking o replicate..


https://www.annovisbio.com/technologies


it is exciting medicine..

[McMagyar]

I like our odds

[Marvy]

Finally I've been in and out of this since $5...now holding 500 shares just to see what the results are

[inbred_dumass]

Thank you for the information.

[McMagyar]

i posted this on Cassava and Anavex Boards, and soon (this Quarter?) I believe Annovis' new drug will be in the same category for ACCESS NOW..

the FDA has allowed(almost feels like FORCED/COERCED/SCARED) tens of millions of Healthy Americans to be subjected to vaccines (Experimental Drugs) which have NEVER been in ONE SINGLE human being for over a year. Tens of millions of your healthy neighbors were coerced/scared into taking these vaccines while they were healthy and even though multiple people around the world have gotten very ill and/or died from taking these vaccines.
98% of your healthy neighbors would have survived the China Virus EVEN if they were not given vaccine. www.c19study.com

Bloody Hell you say..get on with it..

Dementia is a 100% Death Sentence.
OVer 5,000,000 of your fellow Americans have been sentenced to DEATH.

50,000 added to the Dementia DEATH ROLL every month..
Sava's Drug and Anavex's drug have been in human beings -safely- for multiple years..no deaths..no bad side effects...

yet....NOTHING IS DONE TO TRY AND SAVE YOUR 5,000,000 SUFFERING NEIGHBORS AND FAMILY AND FELLOW COUNTRYMEN!

WHY THE HELL NOT?

[McMagyar]

The next driver of which I am aware is the
Data from a recently completed Phase 2 Trial with 68 participants( 14 Alzheimers and 54 Parkinsons) . They have said that data should be available this quarter and with the Biogen Clock of 90 Days ticking ,
I imagine all kitchen sinks will be thrown into the market by ANVS, SAVA and AVXL during this time frame. If they miss this window to stop Biogen it will be a true human tragedy (IMO)

[inbred_dumass]

I though I was the only one watching ANVS...no clue you two from the AVXL board were here and actually invested.

I owned a few thousand shares a while back but sold them because they were not doing anything and, to be honest, knew too little about the company to know when any real catalysts would occur. I saw another opportunity and 'thought' I had time to get back in at the same position or better.

I intend to buy in the near future. Just not sure where a good entry point will be.

Thanks for creating the board.

[grich1]

I agree. I bought as a long hold months ago and I didn’t expect the rising tide to lift this boat too. SAVA is bringing money to the party.

[McMagyar]

Should be a fun ride..
Small float.. big dreams

[grich1]

Thanks for starting this board.

[McMagyar]

Hello, and welcome to Annovis, a very exciting Pharma with a tremendous multi-pronged(4)strategy to attack the ravages of CNS disease.
Early 28 patient (14 Parkinsons and 14 Alzheimers) results are expected within first quarter of 2021. It is a low float Equity(only 7,000,000 shares total) less in Float, and as of February of 2021 the company is MC valued at around $140 Million. Minimum Valuations in My Opinion for successful Dementia -Candidates- are closer to the $1-$3 Billion range,
with higher valuations the closer these drugs come to market.
There are early indications that Annovis expects positive results from this 28 patient cohort as they have filed up to a $250,000,000 shelf registration.

There are currently two drugs which offer great hope in this category, one from Anavex and one from Cassava. We may only hope for more candidates like Annovis to be successful.